Global Cell Isolation Technology Market

MARKET SCOPE:

The global Cell Isolation Technology market is projected to grow significantly, registering a CAGR of 10.2% during the forecast period (2024 – 2032).

Cell isolation technology encompasses a variety of techniques and methods employed to segregate and extract specific types of cells from heterogeneous cell populations, tissues, or organs. The primary objective of cell isolation is to attain a pure and uniform population of target cells for subsequent analysis, experimentation, or therapeutic applications. The selection of a particular cell isolation method hinges on factors such as the cell type, source tissue, intended downstream applications, and the desired level of purity. Density Gradient Centrifugation, for instance, achieves cell separation based on density by layering cells on a density gradient medium and subjecting them to centrifugal forces. This process results in cells of differing densities migrating to distinct layers, facilitating their isolation.

MARKET OVERVIEW:

Driver: The rise in government funding for cell-based research is predicted to foster the market growth.

Cell isolation stands as a crucial step in the development of cell-based treatments, playing a pivotal role in various applications of cell-based research. Recognizing its significance, governmental bodies worldwide have allocated funds to support such research initiatives. For example, in May 2021, the National Institutes of Health (NIH) granted USD 30.0 million to fund research focused on developing innovative tools and technologies for cell studies. This substantial funding was distributed among several institutions in the United States, including Harvard University, the University of California San Francisco, and the University of Texas Southwestern Medical Center. Additionally, through the Government's Medical Research Future Fund (MRFF), the Stem Cell Therapies Mission is investing USD 150.0 million over a span of 10 years. This significant investment aims to advance stem cell research, ultimately enhancing healthcare outcomes. Such financial support is anticipated to propel cell-based research on a global scale, leading to an increased demand for cell isolation products and consequently, boosting the market.

Opportunities: Growth in biopharmaceutical sector is expected to pave the way for market growth in the upcoming years.

Rapid growth is being observed in the biopharmaceutical industries of emerging markets like China, India, and Brazil. This growth is attributed to factors such as increased healthcare spending, a expanding aging population, and a surge in chronic diseases. The heightened demand for biopharmaceuticals in these regions is generating a necessity for cell isolation technologies to facilitate the development and manufacturing of these products. Additionally, emerging markets are actively investing in advanced technologies such as microfluidics, magnetic cell separation, and flow cytometry. This strategic investment is enhancing the efficiency and precision of cell isolation processes, making these technologies more accessible and cost-effective in these expanding markets. Furthermore, there is a notable uptick in research and development activities within these emerging markets. Both governmental and private institutions are channeling investments into research endeavors aimed at creating new therapies and treatments for chronic diseases. As cell isolation plays a crucial role in the development of these therapies, the surge in research activities within these markets is propelling the overall growth of the cell isolation technology market.

COVID IMPACT:

The COVID-19 pandemic has presented a lucrative opportunity for researchers to delve into the study and comprehension of the newly emerged infectious virus, aiming to devise treatments and diagnostic tools. Numerous pharmaceutical and biotech industry leaders have engaged in swift and extensive research and development endeavors to create innovative vaccines, therapies, and testing kits. This surge in research activities has notably heightened the demand for cell isolation tools, particularly in research applications. A concrete example is the initiative launched in February 2021 by the National Institute of Health in the United States, allocating USD 1.5 billion over four years to support investigations focusing on the ""Long COVID: Long-term Effects of COVID-19."" Consequently, with such advancements and ongoing initiatives, the COVID-19 pandemic is anticipated to exert a substantial impact on the growth of the market.

SEGMENTATION ANALYSIS:

The consumable segment is anticipated to grow significantly during the forecast period.

The dominance of the consumable segment in the market can be ascribed to several factors, with one key aspect being the repetitive utilization of consumables in the cell isolation process. Consumables, such as reagents, filters, and disposable instruments, are integral components that are frequently employed in various stages of cell isolation procedures, contributing to their consistent demand. Moreover, the consumable segment's substantial share is influenced by the growing number of regulatory approvals for new consumable products. The continuous advancements in consumable technologies and the approval of innovative products by regulatory authorities enhance the overall efficiency and efficacy of cell isolation processes. As a result, this uptick in regulatory approvals is anticipated to fuel the growth of the consumable segment within the cell isolation technology market.

The instrument segment is anticipated to grow significantly during the forecast period.

Instruments and associated products play a vital role in delivering precise and efficient outcomes, proving essential in areas such as disease diagnosis and scientific research. Despite their indispensable applications, these products often come with high price points, posing a potential constraint on market expansion. Additionally, the techniques involved in these applications incur a broad spectrum of expenses, encompassing costs for equipment, reagents, kits, sera, and services. The experimental setup and the utilization of certain reagents for specific applications contribute to the overall expense. These factors are foreseen to impose limitations on the growth of the industry to some extent throughout the forecast period.

REGIONAL ANALYSIS:

The Europe region is set to witness significant growth during the forecast period.

The European market for cell separation technologies is anticipated to demonstrate consistent growth throughout the forecast period, driven by the expanding network of research laboratories in the region. A notable illustration is AstraZeneca's introduction of a new $1.3 billion research facility in the UK in 2021, dedicated to advancing next-generation therapeutics, including cell therapies. Such initiatives, coupled with an increase in cancer cases and investments by biotech firms in the UK aiming to expedite advancements in drug discovery, are poised to contribute to the heightened growth of the regional industry.

COMPETITIVE ANALYSIS

The global Cell Isolation Technology market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.

Siemens Energy

In May 2019, Thermo Fisher Scientific's acquisition of Brammer Bio is strategically geared towards enhancing capabilities to cater to the rapidly growing gene and cell therapy market. The two companies have officially entered a definitive agreement, with Thermo Fisher set to acquire Brammer Bio for approximately $1.7 billion in cash. Through the synergies of their combined capabilities, substantial commercial scale, and established customer relationships, this move aims to reinforce their standing as a reliable partner for pharmaceutical and biotechnology companies. The overarching objective is to facilitate the development and accessibility of more life-saving treatments for patients.

Akadeum Life Sciences

STEMCELL Technologies

Bio-Rad Laboratories, Inc.

Becton, Dickinson, and Company

Corning Incorporated

Cellenion

Miltenyi Biotec

10X Genomic

Zeiss

Cytena GmbH

PerkinElmer, Inc.

Alfa Laval

pluriSelect Life Science UG

PerfuseCell A/S

SCOPE OF THE REPORT

By Product

Instruments

Consumables & Reagents

By Application

Stem Cell Research

Immunology

Neuroscience

Cancer Research

Others

By Region

North America (the United States & Canada)

Europe (Germany, UK, France, Spain, Italy, and the Rest of Europe)

Asia Pacific (China, Japan, India, and Rest of Asia Pacific)

Rest of the World (the Middle East & Africa, and Latin America)

KEY REASONS TO PURCHASE THIS REPORT

It provides a technological development map over time to understand the industry’s growth rate and indicates how the Cell Isolation Technology market is evolving.

The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Cell Isolation Technology submarket will be the main driver of the overall market from 2024 to 2032.

It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.

It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032. Show more